| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.2 | 8e-09 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.18 | 3e-07 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-07 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.2 | 2e-06 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-06 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-06 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.13 | 2e-05 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0002 |